Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Trygg Pharma

Trygg Pharma
2010 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
3 FINANCING ROUNDS
1 INVESTMENTS
Description

Manufacturer of pharmaceutical products in Norway. The company is engaged in biotechnological research and development, manufacturing and sale of marine based omega-3 fatty acid concentrates for the nutritional supplements market.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • Fjordalléen 16
  • Post Office Box 1423 Vika
  • 0115 Oslo
  • Norway

+47 24 00 00 00

Trygg Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Trygg Pharma‘s full profile, request access.

Request full access to PitchBook

Trygg Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 01-Dec-2010 0000000000 000.00 Pharmaceuticals 00000 000000
To view this company’s complete investment and acquisition history, request access »

Trygg Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 01-Dec-2010 0000000000 000.00 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Trygg Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Trygg Pharma‘s full profile, request access.

Request full access to PitchBook

Trygg Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Aaron Kramer Chief Executive Officer

Trygg Pharma Board Members (4)

Name Representing Role Since Contact
Info
0000 0000 Trygg Pharma Chairman 000 0000

3 Former Board Members

You’re viewing 1 of 4 board members. Get the full list »